Breaking News

Obagi Medical Products, Inc. appointed Mark T. Taylor as senior vice president,

February 1, 2013

Obagi Medical Products, Inc.: appointed Mark T. Taylor as senior vice president, corporate development and investor relations. He comes to Obagi with more than 20 years of experience working with specialty pharmaceutical companies in high-level capacities. Most recently, Taylor was at Roth Capital Partners, LLC where, for over a six-year tenure, he served health care clients in institutional sales, investment banking and equity research. From May of 2003 to October of 2007, he was Roth’s specialty pharmaceutical analyst where he published on as many as 25 companies, including Obagi.
blog comments powered by Disqus
  • Why Attend the IFSCC Congress in Orlando?

    September 26, 2016
    Organizing Chair Guy Padulo supplies a variety of reasons!

  • Restoring Rembrandt

    Restoring Rembrandt

    Christine Esposito, Associate Editor||September 26, 2016
    Ranir LLC has acquired Rembrandt, an iconic name in teeth whitening, and plans to make it a staple in the value segment.

  • Active Agents

    Active Agents

    September 19, 2016
    On the surface, surfactants may seem staid, but the market, and the supplier activity driving it, is bubbling.

  • Back to School

    Back to School

    Tom Branna, Editorial Director||September 1, 2016
    It may be September, but class was in session this summer during the Private Label Manufacturers Association’s Executive Educ

  • What

    What's In Your Formula?

    Christine Esposito, Associate Editor||September 1, 2016
    A look at the ingredients beauty brands are using to fuel their formulations and capture consumers’ attention.

  • A Sweet-Smelling Sanctuary

    A Sweet-Smelling Sanctuary

    Melissa Meisel, Associate Editor||September 1, 2016
    Home fragrance is enhanced by aromatic developments in delivery and components.